Dynamic changes in CCL3 and CCL4 plasma concentrations in patients with chronic lymphocytic leukaemia managed with observation

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|180|4|597-600

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.180, Iss.4, 2018-02, pp. : 597-600

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Detection of Elevated Serum Levels of the Chemokine CCL18 in B-Cell Chronic Lymphocytic Leukaemia: Identification of a Novel Biomarker

By  

Acta Haematologica, Vol. 124, Iss. 2, 2010-08 ,pp. : 110-114

Karger

Access to resources Recommend Favorite

Ofatumumab retreatment and maintenance in fludarabine‐refractory chronic lymphocytic leukaemia patients

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 1, 2015-07 ,pp. : 40-49

John Wiley & Sons Inc

Access to resources Recommend Favorite

Identification of recurrent truncated DDX3X mutations in chronic lymphocytic leukaemia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 3, 2015-05 ,pp. : 445-448

John Wiley & Sons Inc

Access to resources Recommend Favorite

CD4+/CD45RA+ ‘Naive' T Cells and Immunological Response to Influenza Virus Vaccine in B-Cell Chronic Lymphocytic Leukaemia Patients

By  

Acta Haematologica, Vol. 99, Iss. 1, 1998-01 ,pp. : 18-21

Karger

Access to resources Recommend Favorite

CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 5, 2015-12 ,pp. : 726-735

John Wiley & Sons Inc

Access to resources Recommend Favorite